| Hans-Günter Meyer-Thompson | Buprenorphin
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder.
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder.
Greenwald MK, Wiest KL, Haight BR, Laffont CM, Zhao Y.
Harm Reduct J. 2023 Dec 2;20(1):173. doi: 10.1186/s12954-023-00906-7. PMID: 38042801; PMCID: PMC10693082.